Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Creutzfeldt-Jakob disease.

S K Narayan1, J K Dutta

  • 1Department of Neurology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry.

The Journal of the Association of Physicians of India
|December 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuro developmental sequelae of pyogenic meningitis in children.

Neurology India·2018
Same author

Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population.

European journal of clinical pharmacology·2012
Same author

The minimum prevalence of CADASIL in northeast England.

Neurology·2012
Same author

Chronic epidural intracranial actinomycosis: A rare case.

Annals of Indian Academy of Neurology·2010
Same author

Dot-ELISA for the diagnosis of neurocysticercosis.

Revista do Instituto de Medicina Tropical de Sao Paulo·2004
Same author

Trigger autoimmunity -development of multiple plexopathy in a patient with chronic idiopathic thrombocytopenic purpura.

Neurology India·2004

Creutzfeldt-Jakob disease is a rare, fatal prion disease affecting the brain. Advances in diagnostics and treatments present new challenges in controlling this transmissible neurodegenerative condition.

Area of Science:

  • Neurology
  • Prion Diseases
  • Neurodegenerative Disorders

Background:

  • Creutzfeldt-Jakob disease (CJD) is a fatal, transmissible prion disease causing spongiform encephalopathy.
  • The discovery of CJD's pathogenesis by Pruisner in 1982 and the emergence of variant CJD ('mad cow disease') heightened scientific and clinical interest.
  • Sporadic genetic variants of CJD remain a significant challenge for geneticists.

Purpose of the Study:

  • To review the distinct clinical features and novel transmission mechanisms of Creutzfeldt-Jakob disease.
  • To discuss the impact of variant CJD on food safety regulations.
  • To highlight diagnostic advancements and challenges in managing CJD, particularly concerning cadaver-derived therapeutic products.

Main Methods:

  • Review of scientific literature on prion diseases and Creutzfeldt-Jakob disease.

Related Experiment Videos

  • Analysis of diagnostic advancements including neuroimaging, cerebrospinal fluid markers, and genetic studies.
  • Examination of challenges posed by therapeutic products derived from cadaveric sources.

    • Main Results:

    • Neuroimaging, CSF markers, and genetic studies offer improved diagnostic capabilities for CJD.
    • The use of cadaver-derived products (e.g., growth hormone, grafts) introduces new challenges in disease control.
    • Understanding CJD pathogenesis and transmission is crucial for public health and clinical management.

    Conclusions:

    • Creutzfeldt-Jakob disease, a rare prion disorder, presents unique diagnostic and management challenges.
    • Continued research into sporadic genetic variants and control of iatrogenic transmission is essential.
    • Advances in diagnostics aid in identifying CJD, but controlling its spread, especially via medical interventions, requires ongoing vigilance.